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Abstract Several studies have shown that the prevalence
of migraine and tension-type headache (TTH) varied
betweendifferentgeographicalregions.Therefore,thereisa
need of a nationwide prevalence study for headache in our
country, located between Asia and Europe. This nationwide
study was designed to estimate the 1-year prevalence of
migraine and TTH and analyse the clinical features, the
impact as well as the demographic and socio-economic
characteristics of the participant households in Turkey. We
planned toinvestigate 6,000 representative households in21
cities of Turkey; and a total of 5,323 households (response
rate of 89%) aged between 18 and 65 years were examined
forheadacheby33trainedphysiciansathomeonthebasisof
the diagnostic criteria of the second edition of the Interna-
tional Classiﬁcation of Headache Disorders (ICHD-II). The
electronically registered questionnaire was based on the
headache features, the associated symptoms, demographic
and socio-economic situation and history. Of 5,323 partici-
pants (48.8% women; mean age 35.9 ± 12 years) 44.6%
reported recurrent headaches during the last 1 year and 871
were diagnosed with migraine at a prevalence rate of 16.4%
(8.5% in men and 24.6% in women), whereas only 270 were
diagnosed with TTH at a prevalence rate of 5.1% (5.7% in
menand4.5%inwomen).The1-yearprevalenceofprobable
migraine was 12.4% and probable TTH was 9.5% addi-
tionally. The rate of migraine with aura among migraineurs
was 21.5%. The prevalence of migraine was highest among
35–40-year-old women while there were no differences in
agegroupsamongmenandinTTHoverall.Morethan2/3of
migraineurshadeverconsultedaphysicianwhereasonly1/3
of patients with TTH had ever consulted a physician. For
women, the migraine prevalence was higher among the ones
with a lower income, while among men, it did not show any
change by income. Migraine prevalence was lower in those
withalowereducationalstatuscomparedtothosewithahigh
educational status. Chronic daily headache was present in
3.3% and the prevalence of medication overuse headache
was 2.1% in our population. There was an important impact
of migraine with a monthly frequency of 5.9 ± 6, and an
attack duration of 35.1 ± 72 h, but only 4.9% were on
prophylactictreatment.Theone-yearprevalenceofmigraine
estimated as 16.4% was similar or even higher than world-
wide reported migraine prevalence ﬁgures and identical to a
previous nation-wide study conducted in 1998, whereas the
TTH prevalence was much lower using the same method-
ology with the ICHD-II criteria.
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Introduction
Prevalence estimates of migraine as well as tension-type
headache (TTH) show worldwide variations mainly due to
the differences in the deﬁnitions and methodologies of the
studies. It is remarkable, however, that the recent popula-
tion-based studies in adults, all using the diagnostic criteria
of the International Headache Society (IHS), have achieved
similar prevalence rates of migraine. Several European
[1–6] and American studies [7–9] have reported somewhat
congruent prevalence ﬁgures about 10–12% for migraine in
adults,6%amongmenand15–18%amongwomen.Ameta-
analysis indicated that the prevalence of headache and
migraine varied between different geographical regions,
being somewhat lower in Europe than in North America but
higher than in Asia and Africa [10]. So, there is a need for
independent prevalence studies of migraine in different
regions of the world using the IHS criteria.
The prevalence of TTH varied much more widely among
studies, and more attention has been drawn to its importance
during the last years. Even though TTH was known to be the
most prevalent type of headache across all age groups
worldwide [11, 12], there were still relatively few epidemi-
ological studies on TTH. Authors reported that it was a
paradox that the prevalence of TTH seemed higher than that
ofheadacheingeneralintheEuropeanstudies[6]. Therefore,
there is a second need for epidemiological studies investi-
gating the TTH prevalence by strictly using the IHS criteria.
Although there were a few local epidemiological studies
on headache [13–16] in our country located between Asia
and Europe, published nationwide studies assessing the
headache in adults are lacking. In a preliminary nationwide
population-based headache survey in Turkey conducted in
1998 using the criteria of ﬁrst edition of the International
Classiﬁcation of Headache Disorders (ICHD-I, 1988) [17],
migraine prevalence was estimated to be 16.4% and TTH
31.7% among 2,007 households aged between 15 and
55 years [18].
We aimed to investigate the nationwide migraine and
TTH prevalence and analyse the clinical features as well as
the demographic and socio-economic characteristics using
the second edition of the ICHD (ICHD-II, 2004) criteria
[19] for the ﬁrst time in a large sample using a population-
based design in Turkey.
Methods
We designed a nationwide, community- based prevalence
study in adults aged between 18 and 65 years, with face-to-
face interviews by 33 specially trained general practitioner
physicians using a structured electronic questionnaire. The
comprehensive interview form included diagnostic questions
based on the ICHD-II criteria [19] and revised criteria for
chronic migraine and medication overuse headache (MOH)
[20] for diagnoses of migraine, TTH and MOH within the
last 1 year, questions about features of headache and asso-
ciated symptoms, demographic and socio-economic condi-
tions of the participants, information about the previous
physician visits, previous diagnoses, disability assessment
by Turkish version of MIDAS questionnaire [21], acute and
prophylactic medication in migraineurs. TTH was diagnosed
if the participants were not diagnosed with ‘‘deﬁnite’’ or
‘‘probable’’ migraine and fulﬁlled all TTH criteria.
We used a multi-stage sampling strategy, which
involved as the initial stage, the selection of 21 cities rep-
resentative of the characteristics of households in all 7
geographical regions of Turkey based on the ratio of their
population to the total population of Turkey as reported
in the year of 2008 by the Turkish Statistical Institute
(http://rapor.tuik.gov.tr/reports/rwservlet?adnksdb2=&
ENVID=adnksdb2Env&report=turkiye_yasgr.RDF&p_
yil=2008&p_dil=1&desformat=html). Six of the seven
geographical regions of Turkey were each represented by
three different cities and only one last smallest region was
investigated by two representative cities. As the largest city
of Turkey with a high internal migration rate, Istanbul was
considered as a different region and represented by 1,400
households. In the second part of selection, the distribution
of urban and rural populations, gender and age groups were
all taken into account to choose the target population in
these cities, to ensure that there will be no selection bias.
The total population of Turkey with an age range of
18–65 years which was around 40 million was represented
by 6,000 households with an acceptable error rate of
±1.3%. After establishing the total number of households
to be interviewed (for example n = 240 households for the
city of A), this number was further divided by the urban
and rural populations of this speciﬁc city. By the guidance
of the quotas for each city, the houses to be visited were
determined using a simple random-sampling method in
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123districts, streets and rural areas. Only one person was
interviewed in each household to avoid any bias. A Kish
sampling grid was used to select one person per household
to be interviewed. A total of 6,000 households were visited.
After excluding the households visited but not interviewed
because of several reasons such as (‘‘rejecting to be inter-
viewed’’, ‘‘having no time’’, ‘‘non-presence at home’’ etc.),
89% of the households had valid interviews. At the end, the
statistical standard error was ±1.3% within 95% conﬁ-
dence interval for 5,323 interviews, as planned.
The study was completed within 3 months in the year of
2008. Each of the 33 physicians visited 1–3 cities and each
city was visited by 1–10 physicians. In every visited home,
aphysicianaccompaniedbyaninterviewer administeredthe
questionnaire using an electronic palm device connected to
study-headquartersbymobilephonecardtotransferthedata
online.
The role of the physician was to exclude secondary
headaches and medical conditions interfering with the pri-
mary headache disorders, by examining the patients and
reviewing their related investigations such as MRIs, LP
records, sinus radiographs, etc. were available. They inter-
viewed the participants about the previous physician visits
related to headache in detail, discussed about the diagnoses
established and reviewed all the available medical reports.
For example if a participant reported that he had the diag-
nosis of sinusitis, the history about acute and chronic pre-
sentations and temporal relationship with headache attacks
were ascertained after viewing the radiographs.
The headache diagnosis was based on the answers of the
questionnaire, according to the ICHD-II criteria. We used
the 1-year prevalence ﬁgures, indicating the proportion of
the population that had an active disease, which was more
relevant than the lifetime prevalence, which was considered
less reliable due to recall problems. The age groups below
18 years (children) and over 65 years (elderly) were not
included in investigation of the prevalence rate in adults.
The questionnaire assessed the headache features,
diagnosis, headache related impact, demographics, and
disability assessed by the Turkish version of MIDAS
questionnaire. The participants were asked to provide the
mean number of attacks and mean number of days with
headache per month during the last year and the untreated
duration of attack in hours. Aura was described as the
recurrent symptoms starting before or just with the start of
the headache lasting 5 min to 1 h. Five types of aura
namely: visual (hemianopia and ﬂashing lights) somato-
sensory, speech disturbances, vertigo/dizziness and motor
dysfunction were questioned separately.
Descriptive statistics were applied and Chi-square test,
t test and logistic regression test were used for the group
comparisons, where appropriate. We used the SPSS 15
software.
Results
A total of 5,323 participants (2,600 women and 2,723 men)
were reviewed. Of the study population, 82.8% are city
dwellers, 16.4% are borough dwellers and 0.8% are village
dwellers. The ages of participants ranged between 18 and
65 years with a mean of 36.2 ± 12 years for women and
35.7 ± 12 years for men. These distributions of partici-
pants are comparable to the demographics of Turkey as
reported in the year of 2008 by the Turkish Statistical
Institute.
Migraine prevalence
2,376 (44.6%) participants reported recurrent headaches
within the last 1 year, whereas 2,947 were free of recurrent
headaches. Of these 2,376 participants with headache,
1,373 (57.8%) were women and 1,003 (42.2%) were men.
Of the total study population, 871 were diagnosed with
‘‘deﬁnite’’ migraine and the 1-year prevalence of migraine
was estimated to be 16.4%. The details of prevalence of
deﬁnite and probable migraine diagnosed based on the
ICHD-II criteria by gender are shown in Table 1. The rate
for migraine with aura among migraineurs is 21.5%. The
prevalence of migraine is highest among 35–40-year-old
women while there is seemingly no such great difference in
age groups among men (Fig. 1).
TTH prevalence
After excluding the participants who were diagnosed with
‘‘deﬁnite’’ or ‘‘probable’’ migraine, 270 of the remaining
were diagnosed with ‘‘deﬁnite’’ TTH according to the
ICHD-II criteria and the 1-year prevalence of ‘‘deﬁnite’’
TTH was estimated to be 5.1%. All details of the TTH
Table 1 The prevalence of migraine types according to gender in
Turkey
Women,
n = 2,600
(%)
Men,
n = 2,723
(%)
Total,
n = 5,323
(%)
Deﬁnite migraine 640 (24.6) 231 (8.5) 871 (16.4)
Probable migraine 349 (13.4) 313 (11.5) 662 (12.4)
Migraine with aura 135 (5.2) 52 (1.9) 187 (3.5)
Probable migraine with
aura
42 (1.6) 45 (1.7) 87 (1.6)
Chronic migraine 17 (0.7) 6 (0.2) 23 (0.4)
Probable chronic migraine
(with medication
overuse)
56 (2.2) 15 (0.6) 71 (1.3)
Total migraine
(deﬁnite ? probable)
989 (38.0) 544 (20.0) 1,533 (28.8)
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123prevalence regarding rare episodic, frequent episodic and
chronic TTH by gender are presented in Table 2. Figure 1
also shows the percentage of the patients with TTH within
the age groups of the study population, which did not show
any signiﬁcant difference by gender.
Unclassiﬁed headache
Total 69 patients (1.3% of study population) had reported
other types of recurrent headaches not diagnosed as deﬁnite
or probable migraine or TTH. Of these 69 patients with
unclassiﬁed headache, 64 (1.2%) had episodic headache
and 5 (0.09) had chronic headache.
Physician consults and headache diagnoses
The analysis of physician consults for headaches revealed
that more than two-thirds (70.6%) of migraineurs had
consulted a physician, whereas only one-third of the TTH
patients had a physician visit, with a signiﬁcant difference
between the headache groups. Mostly consulted physicians
were neurologists as seen in Fig. 2. Previous headache
diagnoses of patients with migraine and TTH are outlined
in Table 3. In the analysis of migraineurs for previous
diagnosis of their migraine headaches, less than half had
diagnosis of migraine (42.0%) at the ﬁrst physician visit
and only half of migraineurs (51.2%) had diagnosis of
migraine at the ﬁrst or the following visits. Misdiagnoses
included TTH (or psychogenic headache), sinusitis,
hypertension, cervicogenic headache, and headache due to
vision problem, in order of decreasing frequency. One-third
of TTH patients were misdiagnosed with sinusitis, fol-
lowed by other misdiagnoses such as hypertensive or cer-
vicogenic headache, but deﬁnite pure TTH patients
diagnosed with migraine were really rare (1%).
Socio-economic characteristics
Tables 4 and 5 summarize certain socio-economic char-
acteristics of the study population. Migraine prevalence is
higher among unemployed for both genders and house-
wives. In women, migraine prevalence is higher (26.4%)
among the ones with a lower income (less than 1,300 US$
monthly) than the ones with a higher income (20.3%),
while in men, it is the same in the ones with lower income
(8.5%) and the ones with higher income (8.5%). There is
no change in prevalence by income in patients with TTH,
in both genders (Table 5). Regarding the educational status
of participants, migraine prevalence is highest among
illiterates (31.6%) while it is 20.4% among participants
who could read and write only without formal education,
19.1% among primary school graduates (5-year education),
14.2% among junior high school graduates (8-year educa-
tion), 15.0% among high school graduates, and 14.9%
among university graduates. Thus, migraine prevalence is
lower in those with a lower educational status than those
with a high educational status.
Chronic daily headache and medication overuse
headache
Medication overuse headache (MOH) was found in 114
(2.1%) of the total study population according to the
revised criteria of MOH [20], being in 8.2% of patients
with migraine, whereas this ﬁgure was 1.9% among
patients with pure TTH. Chronic daily headache was
diagnosed in 3.3% of the study population. Prevalence rate
is 1.8% for chronic migraine (0.4% for those without
medication overuse and 1.3% for those with medication
overuse), and 0.2% for chronic TTH (0.1% for those
without medication overuse and 0.09% for those with
Table 2 The prevalence of tension-type headache (TTH) types
according to gender in Turkey
Women,
n = 2,600
(%)
Men,
n = 2,723
(%)
Total,
n = 5,323
(%)
Deﬁnite TTH 116 (4.5) 154 (5.7) 270 (5.1)
Rare episodic 81 (3.1) 94 (3.4) 175 (3.3)
Frequent episodic 34 (1.3) 50 (1.8) 84 (1.6)
Chronic 1 (0.04) 10 (0.4) 11 (0.2)
Probable TTH 228 (8.8) 276 (10.1) 504 (9.5)
Rare episodic 157 (6.0) 213 (7.8) 370 (6.9)
Frequent episodic 66 (2.5) 52 (1.9) 118 (2.2)
Chronic 5 (0.2) 11 (0.4) 16 (0.3)
Total TTH
(deﬁnite ? probable)
344 (13.2) 430 (15.8) 774 (14.5)
Fig. 1 Migraine and tension-type headache prevalence in age groups
in relation to gender
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123medication overuse). Chronic daily headache was present
in 10.9% of deﬁnite migraineurs, 7.1% of probable
migraineurs and 4.1% of deﬁnite TTH patients, and 3.2%
of probable TTH patients.
Attack characteristics
We further investigated the attack characteristics, disabil-
ity, and the medication history in migraine sufferers by
gender. Regarding the headache characteristics in migrai-
neurs (Table 6), the average attack number was nearly 6
per month lasting nearly 1.5 days per attack. Attack dura-
tions tended to be shorter in men when compared to women
and women experienced more nausea and allodynia com-
pared to men (Table 6). More than half of the migraineurs
(54.2%) reported that their headache attacks were usually
severe. Of migraineurs who never sought medical advice,
40% had severe headache whereas 60% of those who ever
consulted had severe headache. Of migraineurs, 54.5%
reported headache limited to one side (persistently at one
side or side-shift from attack to attack), 72.9% reported
headache limited to or predominant on one side. In 27.1%
of migraineurs, headache was always equal in both sides.
In the disability assessment of the migraineurs, a
MIDAS score of 1 (none or minor disability due to
migraine) was reported in 54.9% of migraineurs while the
Fig. 2 Cumulative percentage
of visited physicians for
headache. (For example, of
2,376 headache sufferers, 47.1%
consulted neurologist)
Table 3 Previous headache diagnoses of migraineurs and patients with TTH
Patients with deﬁnite migraine Patients with deﬁnite TTH
First Dx of migraine,
n = 615
a (%)
Cumulative Dx of migraine,
n = 615
b (%)
First Dx of TTHs,
n = 89
a (%)
Cumulative Dx of TTHs,
n = 89
b (%)
Migraine 42.0 51.2 1.1 1.1
Tension/psychogenic 22.8 30.1 33.7 43.8
Sinusitis 15.3 18.9 37.1 39.3
Hypertension 3.6 4.1 10.1 11.2
Cervicogenic 2.6 3.9 5.6 9.0
Vision problem 1.0 1.0 0.0 1.1
Other 12.8 14.1 12.4 12.4
Dx diagnosis, TTHs tension-type headache patients
a Diagnosis of ﬁrst physician (one participant has one diagnosis)
b Cumulative percentage of diagnoses made by ﬁrst and other physicians (one participant might have more than one diagnosis)
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123Table 6 Attack characteristics
of migraineurs
a In unpaired t test
b In Chi-square test
c In logistic regression test
d Mean ± SD
Women Men P value Total
Number of attacks per month (mean ± SD) 6.0 ± 6
d 5.7 ± 6N S
a 5.9 ± 6
Attack duration in hours 39.2 ± 78 24.0 ± 49 0.002
a 35.1 ± 72
(mean ± SD)
Headache days per month 6.3 ± 6 6.0 ± 6N S
a 6.2 ± 6
(mean ± SD)
C15 headache days per month (%) 11.4 9.5 NS
b 10.9
Headache severity (%)
Usually mild 5.8 9.5 NS
c 6.8
Usually moderate 39.8 36.8 39.0
Usually severe 54.4 53.7 54.2
Limited to one side 52.2
d 61.0 0.012
b 54.5
Throbbing 83.4 76.6 0.015
b 81.6
Increase with activity 93.8 92.6 NS
b 93.5
With nausea or vomiting 84.4 71.0 0.000
b 80.8
With photophobia 82.7 82.3 NS
b 82.5
With phonophobia 85.8 83.5 NS
b 85.2
With photo- and phonophobia 77.0 77.1 NS
b 77.0
With allodynia 64.1 52.8 0.002
b 61.1
Table 5 Economical proﬁle of participants and migraine prevalence in relation to income groups
Migraine prevalence (%) TTH prevalence (%)
Women
(n = 640
of 2,600)
Men
(n = 231
of 2,723)
Total
(n = 871
of 5,323)
Women
(n = 116
of 2,600)
Men
(n = 154
of 2,723)
Total
(n = 270
of 5,323)
Living area
Metropolitans 24.1 8.1 16.2 4.7 5.6 5.1
Smaller cities or areas 26.1 9.3 16.7 3.8 5.8 4.9
P value NS NS NS NS NS NS
Income (monthly)
\1,300 US$ 26.4 8.5 17.0 4.5 5.8 5.2
C1,300 US$ 20.3 8.5 14.7 4.3 5.3 4.8
P value 0.000 NS 0.028 NS NS NS
P value in Chi-square test
Table 4 Some socio-demographic characteristics of participants and comparison between headache types
Study group (%) Migraine group (%) TTH group (%)
Women
(n = 2,600)
Men
(n = 2,723)
Total
(n = 5,323)
Women
(n = 640)
Men
(n = 231)
Total
(n = 871)
Women
(n = 116)
Men
(n = 154)
Total
(n = 270)
University degree 22.8 23.9 23.4 19.5 26.8 21.5 20.7 25.3 23.3
Housewife/unemployed 48.9 7.6 27.9 58.1 13.4 46.3 53.4 5.8 26.3
City dweller 84.8 80.9 82.8 81.3 84.0 82.0 86.2 77.3 81.1
Monthly income\1,300
US$
70.5 75.0 72.8 75.6 74.9 75.4 71.6 76.6 74.4
House owner 66.2 638 65.0 61.9 64.9 62.7 64.7 59.7 61.9
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123score was 2 (mild disability) in 19.7%, the score was 3
(moderate disability) in 15.8% and ﬁnally, the score was 4
(severe disability) in 9.5%.
Attack medication
As an attack medication, 19.3% of 871 migraineurs
reported the use of simple analgesics, 15.8% combined
analgesics, 41.4% nonsteroidal anti-inﬂammatory drugs
(NSAIDs), 14.5% ergots, and only 2.9% triptans. MOH
was found in 8.2% of migraineurs (8.8% in women and
6.5% in men). Overused medications were simple analge-
sics alone in 4.8% of migraineurs (5.3% in women and 3.5%
in men) or combinations of ergots, triptans and analgesics in
3.3% of migraineurs (3.4% in women and 3.0% in men).
Only in 43.1% of migraineurs, medication advice was
given by physician. Chronic migraine without MOH was
diagnosed in 2.6% of migraineurs (2.7% in women and
2.6% in men).
Prophylactic medication
Although more than half of the migraineurs reported
usually severe headache attacks and 4 or more attacks per
month, only 4.9% were on prophylactic medication with
mostly antidepressants (3.9% at the time of the ques-
tionnaire). Mostly used antidepressants were selective
serotonin reuptake inhibitors (SSRIs) with a current rate
of 2.8% and tricyclics with 1.0%. The current and past
use of other prophylactic treatments such as beta
blockers, ﬂunarizin and antiepileptic drugs were less than
1% each.
Discussion
Our nationwide population-based study estimated the
1-year prevalence of deﬁnite migraine as 16.4%, probable
migraine as 12.4% and of pure TTH as 5.1%, probable
TTH as 9.5% with ICHD-II criteria, constituting a total of
43.4% of the general population suffering from these two
primary headache types. We had planned to reach 6,000
representative households and in the end, a total of 5,323
households were examined for headache. This excellent
response rate of 89% probably reﬂects the conductance of
the study directly by physicians face-to-face rather than
sending a questionnaire. The prevalence of migraine was
highest among 35–40-year-old women while there were no
big differences in age groups among men and in TTH
overall, as shown in Fig. 1.
The striking well-known female preponderance in
patients with migraine which is also evident in our study is
more consistent across studies than the overall prevalence
ﬁgures of migraine [1, 5, 14]. All of the studies reveal that
migraine is [6] two or three times more common in females
than in males. Interestingly, the rates of the present study
using ICHD-II criteria for migraine in adults aged
18–65 years (16.4%) as well as for migraine aura (21.5% in
migraineurs) are identical with the previous largest Turkish
nation-wide headache prevalence study with the partici-
pation of 2,007 households aged between 15 and 55 years
[18] with the ICHD-I criteria. Some studies indicate that
the prevalence of headache and especially of migraine has
been increasing during the last decades in Europe [6, 22,
23]. Although our study showed no signiﬁcant change in
the migraine prevalence compared to the national study of
10 years ago from the present study, the male to female
ratio was 1:3 in the present one while it was 1:2 in the
previous one. Our study with more than the double sample
size in comparison to the former one probably reﬂects the
real gender difference. Although it is well-established that
headache suffering, including migraine, was highly pre-
valent especially in younger women overall in the world,
the differences of headache features between men and
women were thoroughly investigated only in a few studies
[24]. Our study showed that women had a signiﬁcantly
longer attack duration, more nausea and more allodynia in
comparison to men among other differences as seen in
Table 6. A population-based study in the UK reported the
mean headache duration of 28.4 h in men versus 36.7 h in
women along with non-signiﬁcant changes of attack fre-
quency and pain intensity, similar to our results [5]. Several
hypotheses have been proposed to explain these differ-
ences, including ﬂuctuations in sex hormones and receptor
binding, genetic factors, differences in exposure to envi-
ronmental stressors, as well as differences in response to
stress and pain perception [24].
On the contrary of the small changes in the migraine
prevalence around the world, the prevalence of TTH is a
matter of debate and has varied widely among studies.
TTH is known as the most prevalent type of headache
across all age groups worldwide [11]. Nineteen studies
have reported the TTH prevalence in Europe and the
prevalence of current TTH among 66,000 adults was
reported as 62.6%, and chronic TTH (i.e. on 15 days per
month) occurred in 3.3%. Much lower ﬁgures (current TTH
15.9%, chronic TTH 0.9%) were found in the nine studies
among almost 25,000 children and the youth showing the
possible increase with age [6, 23]. The largest American
study with telephone surveys reported a TTH prevalence of
38.3% [11, 25] and higher ﬁgures and lifetime prevalence
around 80% were reported in Denmark [26]. In our study,
TTH prevalence is much lower than most of the other
studies, even after the inclusion of cases with probable
TTH, interestingly. Rare episodic form is the most frequent
form of TTH and followed by frequent episodic form and
J Headache Pain (2012) 13:147–157 153
123lastly chronic TTH is the most infrequent form in both
deﬁnite and probable TTH categories, in our study.
The wide variations in the estimated prevalence of TTH
can result from the methodology, case deﬁnitions, sampling
procedures, possible inﬂuence of the physician/investiga-
tors and the inclusion or exclusion of cases of infrequent
episodic TTH and overlap with probable migraine. We
applied the ICHD-II 2004 criteria very strictly, without
allowing any inﬂuence of the physician. It is also highly
likely that some unknown genetic factors besides variables
such as environmental risk factors or culturally determined
differences in symptom reporting may further explain this
discrepancy. It is important to note that in this study, TTH
was a diagnosis of exclusion and it was only diagnosed in
headache sufferers if deﬁnite or probable migraine were
not diagnosed according to ICHD-II criteria. Hence, this
could be one of the important reasons that the TTH rate
in our study is not as high as the previous study in our
country [18].
The difference of results between these two Turkish
headache epidemiological studies can also be evaluated,
considering the continuum hypothesis as a basis. The two
ends of headache spectrum are TTH and migraine, both
might evolve into other during time or from one attack to
another. Mixed headache, so called TTH and migraine in
the same individual, is accepted as the occurrence of
spectrum of headache in the same individual [27]. Both
adolescent and adult studies have shown that headache
might evolve into both ends of spectrum [28, 29]. Thus, the
low prevalence of TTH might be the evidence of evolving
of TTH into probable migraine/migraine by some external
or internal modiﬁers such as socio-economic difﬁculties or
hormonal changes.
Another alternative conceptual approach, the ‘‘severity
model’’ of headache, considers a continuum of headache
ranging from mild to severe forms with speciﬁc headache
subtypes distinguished by level of severity rather than
unique constellations of symptoms [30].
Stovner and Colette [6] compared the results from the
studies using different methods of data collection and
reported that only for migraine and headache in general
could meaningful comparisons be made; in relation to
TTH, there were too few studies available. Most ques-
tionnaire studies use somewhat modiﬁed criteria, whereas
studies based on personal interviews seem to give some-
what higher prevalence than those using questionnaires.
The ways the ICHD criteria are applied and the diagnoses
included are also of great importance. The problem of
multiple headache types occurring in the same patient may
represent problems in headache epidemiologic studies. One
diagnostic dilemma is the overlap between TTH and
probable migraine. It is well-known in clinical practice that
many patients have comorbid TTH and migraine, or in
other words many migraineurs may experience headaches
very similar to TTH in some of their attacks. Thus, the
trend and thoughts of the physician could affect the diag-
nosis. Being aware of this, our study was based on the strict
computerized application of ICHD-II criteria aiming to
exclude the subjectivity of the conducting physicians.
Furthermore, some individuals suffer from infrequent, not
disturbing headaches and could not remember the exact
proﬁle. It is also known that subjects’ headache symptoms
might change during a given period or they might even
forget that they had experienced headache [29]. All these
factors pose difﬁculties in diagnosing headache in the
population based epidemiological studies. This is particu-
larly true for the probable headache diagnoses. Using
ICHD-II criteria strictly, we showed that pure TTH is
indeed rare. In ICHD-II, fulﬁlment of the diagnostic cri-
teria for main groups of migraine and TTH or any of their
subtypes, always trumps fulﬁlment of criteria for the
probable diagnostic categories [19].
Although many studies investigated the prevalence of
migraine and TTH in Western Europe and North America,
there are only a few studies carried out in Eastern Europe.
In the Republic of Georgia, an eastern neighbour of our
country, one-year prevalence was estimated to be 6.5% for
migraine, 9.2% for probable migraine (all migraine
15.6%), 10.0% for TTH, 27.3% for probable TTH (all TTH
37.3%) in a community-based door-to-door survey, con-
ducted by four medical residents [31]. So they found a
lower rate for migraine but a higher rate for TTH in
comparison to our results. Another study from Croatia
located also in the eastern bank of Europe reported a crude
and lower prevalence of TTH as 21.2% [32]. It is inter-
esting to note that both of these studies also showed rela-
tively low prevalence rates of TTH, like in our study.
Whether these regional differences are real or mainly a
result of differences in the methodology and conduction of
the studies is uncertain.
The prevalence of chronic daily headache (C15 head-
ache days per month) was 3.3% in our nationwide study,
similar to many studies worldwide [12, 33–36]. Interest-
ingly, an unusually high prevalence of chronic headache
with a rate of 7.6% was reported from Georgia associated
with a low socioeconomic status [31], showing variability
of headache disorders, even in neighbours. Another popu-
lation-based study from Far East of chronic daily headache
in 3,377 participants reported a prevalence of 3.2% being
higher in women (4.3%) than men (1.9%) similar to our
results [35]. A 2.1% prevalence rate for MOH in our total
study population seems to be some higher than reported
rates before [31, 35, 37–39], however, recent studies
reported higher rates of MOH in general population as in
our study [34, 40, 41]. A reason for high rate of MOH in
our study population might be related with low rate of
154 J Headache Pain (2012) 13:147–157
123prophylactic medication use which is 4.9% among
migraineurs.
Although migraine is a remarkably common cause of
temporary disability worldwide, many migraine sufferers
have never consulted a physician. While 47.0% of
migraineurs had physician consult for their headache in
1998 [18] in Turkey, this ratio has raised to 70.6% in
10 years. Though consultation rates have increased remar-
kably the underlying epidemiology of migraine remains
stable over a decade in our country. Thus, our data support
that there is no evidence of increasing prevalence of
migraine with increased awareness. On the other hand, only
one-thirdoftheTTHpatients hadeverconsultedaphysician
in 2008. Mostly consulted physicians were neurologists as
seen inFig. 2.Primarycare physicians, who are supposed to
be the ﬁrst to consult for headache, were far less than neu-
rologists in our country, reﬂecting the choice of the patients.
A study from United States reported that 66.1% of migrai-
neurs (68.1% in females and 57.3% in males) had ever
consulted a physician [42]. While in this American study
61% of migraineurs who never consulted reported severe
headache, in our study 40% of migraineurs who never
consulted had usually severe headache. Of migraineurs who
never consulted, 47.6% had 4 or more attack frequency per
month, 14.1% had more than 1.5 days average attack dura-
tion and 21.5% had more than 6 headache days per month
whereas of those who ever consulted, 57.4% had 4 or more
attack frequency per month, 28.4% had more than 1.5 days
average attack duration and 36.4% had more than 6 head-
ache days per month. These facts reﬂected that there were
still some patients with signiﬁcant impact of migraine who
did not consult for their headaches.
Prevalence studies exploring the relation between socio-
economic status (SES) and headache have shown some
conﬂicting results. The present study revealed a negative
correlation of migraine prevalence with educational status
unrelated to gender and with socioeconomic status only in
women. Higher prevalence with lower educational status/
lower income was reported in some other studies [1, 10,
42–44]. This contradicts the usual clinical perception that
migraine is a disease of rich people. In previous studies
done in Turkey, there was a positive correlation showing
higher migraine prevalence with higher educational status
[13, 45, 46]. These studies are possibly reﬂecting that
people with higher income/education are far more likely to
consult a physician or volunteer to participate in a study. In
three very large population based studies in United States,
the decline of migraine prevalence with increased income
or education has been explained by ‘‘social causation
hypothesis’’ such as ‘‘factors with low socioeconomic
status increase migraine prevalence’’ and ‘‘social selection
hypothesis’’ such as ‘‘migraine-related dysfunction inter-
feres with educational and occupational functioning
leading to low income and low education’’ [42–44]. A
prospective study analysing the relation between SES and
risk of headache in Norway showed that low SES was
associated with increased risk of frequent and chronic
headache at follow-up [47]. Interestingly, the risk of fre-
quent and chronic headache decreased with increasing
individual income, but only among men [47], showing
again a gender difference of SES with migraine.
Every type of misdiagnosis is still very common both for
migraine and TTH in our country as shown in Table 3.
Furthermore, prophylactic medication usage was unex-
pectedly low (4.9%), even though neurologists were in
charge for headache care for most of the patients. These
points draw attention to the need of continuing education
for headache management for physicians and for public to
lift the real burden. The headache lectures and courses
addressed mostly secondary headaches in the medical
curriculum and seemed not be sufﬁcient for appropriate
management of primary headaches, taking the overall
burden in daily life into account. Moreover, the optimal
visit duration of headache patients should not be short. This
is one of most limiting problems of Turkish neurologists
who should examine huge numbers of patients every day.
There are some strong points of our study including
face-to-face assessment of headaches by a speciﬁcally
trained physician group with electronic database system, a
large nation-wide sample size and a random population,
strict application of the ICHD-II diagnostic criteria of the
IHS excluding the subjectivity of the physician’s diagnosis.
However, there is an unavoidable risk of the effect of the
question style even with the same questions and with an
electronic recording system. Due to the higher impact of
migraine in clinical practice in our country [45] it is pos-
sible that the physicians are more prone to handling the
migraine patients than the TTH sufferers.
In conclusion, our study showed a 16.4% prevalence
rate of migraine in Turkey, and it is similar or even higher
than the well-established prevalence ﬁgures of migraine
worldwide. Although there are still misdiagnoses, the
rate of physician consults for migraine has remarkably
increased to 70.6%, whereas the rate of migraineurs on
prophylactic treatment is still lower than expected. Finally,
the prevalence of TTH with strict application of the 2004
ICHD-II diagnostic criteria is very low in our study (5.1%
for deﬁnite TTH and 9.5% for probable TTH), a ﬁnding
which could reﬂect some unknown genetic, cultural,
environmental factors or methodological differences in the
study designs.
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